VXRT - 3 Best Biotech Stocks of 2020: Are They Buys Now?
This year, investors flocked to companies trying to solve two of today's biggest health problems: COVID-19 and cancer. Players in these fields took the three top spots in 2020 biotech share performance, each surging more than 1,000%. In fact, they weren't only the best performers in biotech. They posted steeper gains than any other stock with a market value of $200 million or more -- all industries included.
As we look for stocks to buy in the coming year, it's natural to consider the current year's strong performers. After all, this might be just the beginning of their share growth story -- even if recent increases were big. So, without further ado, let's take a closer look at Novavax (NASDAQ: NVAX) , Vaxart (NASDAQ: VXRT) , and Cardiff Oncology (NASDAQ: CRDF) to determine whether these shares may climb even higher in 2021.
Image source: Getty Images.
For further details see:
3 Best Biotech Stocks of 2020: Are They Buys Now?